Avertix is a medical implant company focused on improving long-term management and outcomes of high-risk coronary disease in patients who have survived one or more heart attacks.
Arogo's target sectors include electric vehicles (EV) technology, smart mobility or sustainable transportation and related business ecosystem in Asia Pacific, primarily South East Asia.
The Hong Kong-based SPAC is sponored by Lion Group Holding and plans to target high growth businesses with enterprise values between $150 million and $300 million.
Proceeds totaled approximately $31.9 million, including funds held in Tottenham’s trust and concurrent PIPE financing led by existing Clene shareholders.